The fast pace of innovation in IT offers compelling investment opportunities

Truffle Capital is a pioneer investor in the exciting field of Energy

Biotechnology has radically transformed medicine over the past 25 years


  • “ An industrial partner, demanding and understanding at the same time, who knows that value creation is a long term process. ”Wittycell et PlasmaPrime
    Miguel Sieler, Chairman

Truffle Capital is an independent European venture capital firm

Truffle Capital is an independent venture capital firm investing in Europe. Established in 2001 and with over €585 million under management and advisory as of the 31st of December 2013, Truffle Capital is an important and independent European private equity firm, specialized in investments in spin-offs from companies active in the Energy, Information Technology and Life Sciences sectors. The firm is led by a team of three General Partners with decades of successful investment and entrepreneurial experience in both Europe and in the USA.

Backed by an investment team of international experts and an experienced support team, a total of 16 professionals, Truffle Capital aims to achieve superior financial returns by leveraging its industry knowledge, extensive network, and operational experience to identify business opportunities that match latent market needs.


03-2014

TRUFFLE CAPITAL

Le 25 mars 2014 – Truffle Capital se sépare de Jean-François Fourt le 31 mars 2014

Pdf


+ read more
03-2014

DEINOVE

19th March 2014 – ANNUAL RESULTS FOR THE FISCAL YEAR 2013

Pdf


+ read more
03-2014

VEXIM

18th March 2014 – 2013 annual results

Pdf


+ read more
03-2014

CARMAT

17th March 2014 – CARMAT is continuing to analyze the first prosthesis, implanted for 74 days

Pdf


+ read more